Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
A graphic of the flag of Australia alt
A graphic of the flag of Argentina alt
A graphic of the flag of Brazil alt
A graphic of the flag of Chile alt
A graphic of the national flag of the People's Republic of China alt
A graphic of the national flag of Colombia alt
A graphic of the national flag of Ecuador alt
A graphic of the flag of Germany alt
A graphic of the national flag of India alt
A graphic of the national flag of Japan alt
A graphic of the flag of Mexico alt
A graphic of the flag of Paraguay alt
A graphic of the flag of Peru alt
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
A graphic of the national flag of Uruguay alt
A graphic of the flag of Venezuela alt
Illustration of people examining large charts and graphs alt
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
21
Latest News

What You Need to Know About Johnson & Johnson's 2022 Second-Quarter Earnings

Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
21
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Today's Top Reads Close
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
21
expand

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.

"We are proud to have delivered on the robust operational guidance that we set forth at the beginning of the year, as we’ve continued to advance breakthrough innovation and foster patient access to make a positive impact across many areas of healthcare," says Joe Wolk Joe WolkExecutive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "Johnson & Johnson is strongly positioned to continue making progress on our business priorities, including the creation of the New Consumer Health Company, to deliver both near- and long-term value to all of our Credo stakeholders.”

For more details about the company's 2022 second-quarter results, and to read a message from Chief Executive Officer Joaquin Duato Joaquin DuatoChief Executive Officer, Johnson & Johnson, here's an infographic that highlights key stats.


Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
21
expand Johnson & Johnson Q2 2022 earnings infographic

Read the earnings press release, which includes full financial data for the second quarter of 2022.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
21

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue